SELECTIVE TARGETING OF MDMX TO TREAT BREAST CANCER

Grant number: 1123057 | Funding period: 2017 - 2019

Completed

Abstract

Breast cancer (BrCa) is a leading cause of cancer death in women worldwide. BrCas unable to respond to current therapies have the worst outcomes. We propose a novel strategy to treat these cancers, based on our new findings. Our two protein targets are: (1) MDMX, that we found drives BrCa with its partner, (2) mutant p53, which causes cancer spread. We plan to directly target these drivers of aggressive BrCas, using new drugs that individually show great promise in trials in a number of cance

Related publications (6)

Researchers